Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan:
a retrospective analysis by the Kansai Myeloma Forum.
京都府立医科大学 木元弥生 Int J Hematol. 2018 May;107(5):541-550.
![](https://myeloma.jp/wp-content/themes/cocoon-master/screenshot.jpg)
Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan:
a retrospective analysis by the Kansai Myeloma Forum.